Although patients with DH lymphomas showed inferior PFS and OS when treated with R-CHOP [60], the prognostic impact of MYC and BCL2 (over)expression in DLBCL in DE lymphomas and HGBL-NOS is still not clear [61,62,63,64,65]. This evidence concerns the gene BCL2 and lymphoma.